Company Monitoring Page for AstraZeneca

latest headlines for company on cafepharma

ASH: Novartis says rare disease med 'stands on its own,' diving deeper into head-to-head win against AstraZeneca
Fierce Biotech
Tue, 12/13/22 - 10:28 am
Tags:
ASH 2022, Novartis, iptacopan, AstraZeneca
ASH: Roche records phase 3 rare disease win ahead of Soliris showdown
Fierce Biotech
Mon, 12/12/22 - 10:29 am
Tags:
ASH 2022, Roche, PNH, crovalimab, AstraZeneca, Soliris
AstraZeneca-Daiichi Sankyo’s therapy shows response in breast cancer trials
Clinical Trials Arena
Mon, 12/12/22 - 10:26 am
Tags:
AstraZeneca, Daiichi Sankyo, clinical trials, datopotamab deruxtecan, metastatic triple-negative breast cancer, breast cancer
SABCS: AZ writes the 'next chapter' in Enhertu's saga with head-to-head win versus Roche's Kadcyla
Fierce Pharma
Fri, 12/9/22 - 10:54 am
Tags:
SABCS, AstraZeneca, Enhertu, breast cancer, Daiichi Sankyo, Roche, Kadcyla
Setting the Stage for ASH 2022
BioSpace
Fri, 12/9/22 - 10:50 am
Tags:
ASH 2022, AstraZeneca, Janssen, Merck, Vega Therapeutics
Chasing Gilead, AstraZeneca-Daiichi lay down phase 2 breast cancer data for antibody-drug conjugate
Fierce Biotech
Fri, 12/9/22 - 10:46 am
Tags:
AstraZeneca, Daiichi Sankyo, breast cancer, antibody-drug conjugate, clinical trials, Gilead Sciences
With Neogene buy and a CAR-T in the clinic, AstraZeneca builds up cell therapy 'library'
Fierce Biotech
Mon, 12/5/22 - 11:04 am
Tags:
AstraZeneca, Neogene Therapeutics, CAR-T, cell therapy, cell library
AstraZeneca Deepens Cancer Cell Therapy Portfolio with Neogene Buyout
BioSpace
Tue, 11/29/22 - 11:12 am
Tags:
AstraZeneca, Neogene Therapeutics, M&A, cancer, cell therapy
Lundbeck-partnered preclinical biotech nabs Series A from AstraZeneca
Endpoints
Tue, 11/29/22 - 11:00 am
Tags:
Rgenta Therapeutics, AstraZeneca, funding, small molecule drugs
The problem with Her2-low testing
EP Vantage
Mon, 11/28/22 - 07:34 pm
Tags:
AstraZeneca, Daiichi Sankyo, Enhertu, breast cancer, diagnostics, HER2-low breast cancer
AstraZeneca, C4XD sign exclusive $402 million global license
Pharmaphorum
Mon, 11/28/22 - 10:20 am
Tags:
AstraZeneca, C4XD, drug development, COPD
Pulling back the curtain on AstraZeneca’s CAR-T work
EP Vantage
Fri, 11/18/22 - 10:23 am
Tags:
AstraZeneca, CAR-T, AZD0754, cell theray
GSK, J&J and AZ top global drug access index, but foundation says plenty more work needs to be done
Fierce Pharma
Thu, 11/17/22 - 12:13 pm
Tags:
GSK, JNJ, AstraZeneca, Access to Medicine Foundation, drug access
AstraZeneca Launches Phase II Trial of Anti-TIGIT NSCLC Therapy
BioSpace
Wed, 11/16/22 - 11:24 pm
Tags:
AstraZeneca, clinical trials, non-small lung cancer, AZD2936
AstraZeneca and Sanofi win big as Europe's human medicines committee endorses approvals, label expansions
Fierce Pharma
Mon, 11/14/22 - 07:10 pm
Tags:
Europe, AstraZeneca, Sanofi, COVID-19, cancer, GSK, Regeneron
AZ claims another Imjudo approval, in big first-line NSCLC market
Pharmaphorum
Fri, 11/11/22 - 10:53 am
Tags:
AstraZeneca, FDA, Imjudo, non-small cell lung cancer
AstraZeneca total revenue soars 19% in Q3
Medical Marketing and Media
Thu, 11/10/22 - 10:18 pm
Tags:
AstraZeneca, earning
AstraZeneca withdraws US COVID vaccine application, shifts focus to antibody treatments
Fierce Pharma
Thu, 11/10/22 - 10:37 am
Tags:
AstraZeneca, vaccines, COVID-19
Yes, no, maybe: FDA panel delivers mixed verdict on AstraZeneca's asthma rescue medication
Fierce Biotech
Wed, 11/9/22 - 10:43 am
Tags:
AstraZeneca, asthma, PT027, FDA
Eli Lilly, Boehringer Ingelheim bolster case for Jardiance to treat chronic kidney disease
Fierce Pharma
Sun, 11/6/22 - 01:44 pm
Tags:
Eli Lilly, Boehringer Ingelheim, chronic kideny disease, Jardiance, Farxiga, AstraZeneca

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.